🇺🇸 FDA
Patent

US 10399993

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

granted A61KA61K31/203A61K31/496

Quick answer

US patent 10399993 (Oxabicycloheptanes and oxabicycloheptenes, their preparation and use) held by Lixte Biotechnology, Inc. expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/203, A61K31/496, A61P, A61P31/10